ASCO Releases Position Statement on Home Infusion of Anticancer Treatments
ASCO raises concerns about the home infusion of anticancer therapies including patient and caregiver safety, adequate oncology infusion nurses, and reimbursement issues.
Oncology
The Twitter Effect on How Oncologists Conduct and Share Research
The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
Restructured Process Overcomes Barriers to Prior Authorization for Proton Therapy
This study examined the impact of a restructured prior authorization process on the delivery of PBT at a proton therapy center.
New Evidence Supports Update of ASCO Guidelines on Prevention, Treatment of CIPN
A literature search of new studies clarifies, refutes, and expands on previous recommendations for managing new and established CIPN in patients treated with cytotoxic agents.
Music Therapy Effective at Reducing Fatigue Among Patients With Cancer
A cross-sectional mixed-method study demonstrated that music therapy diminished cancer-related fatigue.
Radiotherapy for Cervical Cancer: An Introduction to ASTRO’s Clinical Practice Guideline
The consensus guideline, drafted by an ASTRO-convened expert task force, offers recommendations about radiotherapy, including brachytherapy, and chemoradiation, in different stage-of-disease and treatment-strategy settings.
Pregnancy After BRCA-Mutated Breast Cancer Deemed Safe
Pregnancy was not linked to differences in survival outcomes.
Lung Cancer Trials Supported by the Pharmaceutical Industry More Likely to Report Strong Evidence, Be Open Access
A study of clinical trials found no evidence of bias in the reporting of clinical trials supported by pharmaceutical companies compared with studies that had other funding sources.
Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19
Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
-
Loading...
-
Loading...
Next post in Medicine
